Figure 7From: Safety and pharmacological characterization of the molecular tweezer CLR01 – a broad-spectrum inhibitor of amyloid proteins’ toxicity Percent brain penetration of CLR01 at 1 h. Percent of CLR01 radioactivity per g of brain was calculated as a function of blood radioactivity levels per ml at 1 h following IV administration of CLR01 ((CPM/g)/(CPM/ml) × 100). Data are given as mean ± SEM. *p < 0.05.Back to article page